Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17488876rdf:typepubmed:Citationlld:pubmed
pubmed-article:17488876lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0018939lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0026986lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0002351lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0206153lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C2323499lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C0332285lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C1514463lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C1515568lld:lifeskim
pubmed-article:17488876lifeskim:mentionsumls-concept:C2348205lld:lifeskim
pubmed-article:17488876pubmed:issue4lld:pubmed
pubmed-article:17488876pubmed:dateCreated2007-8-6lld:pubmed
pubmed-article:17488876pubmed:abstractTextWe analyzed outcomes after hematopoietic cell transplantation (HCT) in 257 patients, 3 to 72.7 years old (median, 43 y), with secondary myelodysplastic syndrome (MDS) including those with transformation to acute myeloid leukemia (tAML). Conditioning regimens included high-dose total-body irradiation (TBI)/chemotherapy (n = 83); busulfan (BU)/cyclophosphamide (CY) (BUCY, n = 122; with BU targeting [tBUCY], n = 93); fludarabine (Flu) with tBU (FLUtBU; n = 12); Flu plus 200 cGy TBI (n = 26); and miscellaneous regimens (n = 14). Donors were HLA-identical or partially mismatched family members in 135 and unrelated individuals in 122 patients. Five-year relapse-free survival was highest (43%) and nonrelapse mortality lowest (28%) among tBUCY-conditioned patients. Outcomes were compared with results in 339 patients who received transplants for de novo MDS/tAML, and a multivariate analysis failed to show significant differences in outcome between the 2 cohorts. Relapse probability and relapse-free survival correlated significantly with disease stage (P < .001) and karyotype (P < .001). Relapse incidence was lower (P = .003) and relapse-free survival superior (P = .02) with unrelated donor transplants. The data suggest that overall inferior outcome in patients with secondary MDS/tAML was related to the frequency of high-risk cytogenetics. For both cohorts, transplantation outcomes improved over the time interval studied.lld:pubmed
pubmed-article:17488876pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:languageenglld:pubmed
pubmed-article:17488876pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17488876pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17488876pubmed:statusMEDLINElld:pubmed
pubmed-article:17488876pubmed:monthAuglld:pubmed
pubmed-article:17488876pubmed:issn0006-4971lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:AppelbaumFred...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:StorbRainerRlld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:FlowersMary...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:SandersJean...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:HansenJohn...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:DeegH...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:SandmaierBren...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:ShulmanHoward...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:ScottBart LBLlld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:NashRichard...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:ChangChunkang...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:WitherspoonRo...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:StorerBarry...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:BryantEileen...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:ClurmanBruce...lld:pubmed
pubmed-article:17488876pubmed:authorpubmed-author:BedalovAntoni...lld:pubmed
pubmed-article:17488876pubmed:issnTypePrintlld:pubmed
pubmed-article:17488876pubmed:day15lld:pubmed
pubmed-article:17488876pubmed:volume110lld:pubmed
pubmed-article:17488876pubmed:ownerNLMlld:pubmed
pubmed-article:17488876pubmed:authorsCompleteYlld:pubmed
pubmed-article:17488876pubmed:pagination1379-87lld:pubmed
pubmed-article:17488876pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
pubmed-article:17488876pubmed:meshHeadingpubmed-meshheading:17488876...lld:pubmed
More...